Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe
Easy approval and clear terms
BPC-157 helps heal and protect the gastrointestinal tract, potentially improving nutrient absorption and reducing inflammation that can affect energy levels and mood
Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP)
The impressive weight loss results observed in clinical trials suggest that this medication could offer a more promising alternative to existing obesity treatments, potentially helping individuals achieve their weight management goals and improve their overall health and quality of life
Repeat to desired dosage or as directed by your health care professional
